{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:22:37Z","timestamp":1790716957615,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011957","name":"Takeda Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004358","name":"Samsung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005309","name":"Alzheimer Society of B.C.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.bpg.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T20:24:42Z","timestamp":1550262282000},"page":"101603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Targeting anti-fibrotic pathways in Crohn\u2019s disease \u2013 The final frontier?"],"prefix":"10.1016","volume":"38-39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-9948","authenticated-orcid":false,"given":"Christopher","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Jairath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Click","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2019.02.005_bib1","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn\u2019s disease","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2019.02.005_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/gut.49.6.777","article-title":"Behaviour of Crohn\u2019s disease according to the Vienna classification: changing pattern over the course of the disease","volume":"49","author":"Louis","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2019.02.005_bib3","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2019.02.005_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00004836-200309000-00005","article-title":"Natural history and clinical behavior of Crohn\u2019s disease extending beyond two decades","volume":"37","author":"Freeman","year":"2003","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2019.02.005_bib6","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2019.02.005_bib7","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpg.2019.02.005_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00365521.2014.968863","article-title":"Mechanisms of initiation and progression of intestinal fibrosis in IBD","volume":"50","author":"Latella","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib9","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/gutjnl-2012-304353","article-title":"Crohn\u2019s disease complicated by strictures: a systematic review","volume":"62","author":"Rieder","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2019.02.005_bib10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.bpg.2019.02.005_bib11","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.crohns.2014.03.008","article-title":"Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD","volume":"8","author":"Latella","year":"2014","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.bpg.2019.02.005_bib12","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.1401779","article-title":"Noncanonical STAT3 activation regulates excess TGF-beta1 and collagen I expression in muscle of stricturing Crohn\u2019s disease","volume":"194","author":"Li","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bpg.2019.02.005_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ibd.21351","article-title":"Endogenous IGFBP-3 regulates excess collagen expression in intestinal smooth muscle cells of Crohn\u2019s disease strictures","volume":"17","author":"Flynn","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF02234738","article-title":"Connective tissue changes in ileal Crohn\u2019s disease: relationship to disease phenotype and ulcer-associated cell lineage","volume":"44","author":"Borley","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.bpg.2019.02.005_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/106689690100900404","article-title":"Tenascin and strictures in inflammatory bowel disease: an immunohistochemical study","volume":"9","author":"Geboes","year":"2001","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.bpg.2019.02.005_bib16","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.5858\/2001-125-1331-OMOTSB","article-title":"Obliterative muscularization of the small bowel submucosa in Crohn disease - a possible mechanism of small bowel obstruction","volume":"125","author":"Koukoulis","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.bpg.2019.02.005_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ecco-jcc\/jjw126","article-title":"Smooth muscle hyperplasia\/hypertrophy is the most prominent histological change in crohn\u2019s fibrostenosing bowel strictures: a semiquantitative analysis by using a novel histological grading scheme","volume":"11","author":"Chen","year":"2017","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.bpg.2019.02.005_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000449079","article-title":"Pathogenesis of intestinal fibrosis in inflammatory bowel disease and perspectives for therapeutic implication","volume":"35","author":"Bettenworth","year":"2017","journal-title":"Dig Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13148-016-0193-6","article-title":"Genome-wide analysis of DNA methylation and gene expression defines molecular characteristics of Crohn\u2019s disease-associated fibrosis","volume":"8","author":"Sadler","year":"2016","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.bpg.2019.02.005_bib20","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/ki.1997.188","article-title":"Latent transforming growth factor-beta: structural features and mechanisms of activation","volume":"51","author":"Munger","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.bpg.2019.02.005_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrgastro.2009.31","article-title":"Intestinal fibrosis in IBD--a dynamic, multifactorial process","volume":"6","author":"Rieder","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2019.02.005_bib22","first-page":"1283","article-title":"Can we prevent, reduce or reverse intestinal fibrosis in IBD?","volume":"17","author":"Latella","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.bpg.2019.02.005_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/gut.2008.149096","article-title":"Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn\u2019s disease strictures","volume":"58","author":"Di Sabatino","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2019.02.005_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","article-title":"Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease","volume":"12","author":"Gorelik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.bpg.2019.02.005_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MOG.0000000000000119","article-title":"Central role of IL-17\/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis","volume":"30","author":"Ray","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052332","article-title":"IL-13 promotes collagen accumulation in Crohn\u2019s disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells?","volume":"7","author":"Bailey","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bpg.2019.02.005_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm1332","article-title":"IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis","volume":"12","author":"Fichtner-Feigl","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.bpg.2019.02.005_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1751-2980.2012.00607.x","article-title":"Dynamic progress of 2,4,6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model","volume":"13","author":"Zhu","year":"2012","journal-title":"J\u00a0Digest Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib29","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin-17A in the development of skin fibrosis in mice","volume":"64","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpg.2019.02.005_bib30","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.4049\/jimmunol.1004081","article-title":"Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms","volume":"187","author":"Mi","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bpg.2019.02.005_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-1536-6-13","article-title":"The role of interleukin 17 in Crohn\u2019s disease-associated intestinal fibrosis","volume":"6","author":"Biancheri","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bpg.2019.02.005_bib32","first-page":"1491","article-title":"Cellular and molecular mediators of intestinal fibrosis","volume":"11","author":"Lawrance","year":"2017","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.bpg.2019.02.005_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ibd.21344","article-title":"Specific differences in migratory function of myofibroblasts isolated from Crohn\u2019s disease fistulae and strictures","volume":"17","author":"Meier","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"Duffield","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpg.2019.02.005_bib35","doi-asserted-by":"crossref","first-page":"G323","DOI":"10.1152\/ajpgi.00394.2009","article-title":"Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis","volume":"298","author":"Popov","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bpg.2019.02.005_bib36","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1172\/JCI31546","article-title":"IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice","volume":"117","author":"Wilson","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpg.2019.02.005_bib37","doi-asserted-by":"crossref","first-page":"20202","DOI":"10.1074\/jbc.M110.102012","article-title":"Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis","volume":"285","author":"Flier","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bpg.2019.02.005_bib38","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.ajpath.2011.07.042","article-title":"Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis","volume":"179","author":"Rieder","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpg.2019.02.005_bib39","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bpg.2019.02.005_bib40","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.4161\/cc.9.22.14048","article-title":"Metformin against TGFbeta-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis","volume":"9","author":"Cufi","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bpg.2019.02.005_bib41","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI39675","article-title":"EMT: when epithelial cells decide to become mesenchymal-like cells","volume":"119","author":"Kalluri","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpg.2019.02.005_bib42","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.4049\/jimmunol.179.10.6988","article-title":"Differential expression of inflammatory and fibrogenic genes and their regulation by NF-kappaB inhibition in a mouse model of chronic colitis","volume":"179","author":"Wu","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bpg.2019.02.005_bib43","first-page":"358","article-title":"Crohn\u2019s disease fibroblasts overproduce the novel protein KIAA1199 to create proinflammatory hyaluronan fragments","volume":"2","author":"Soroosh","year":"2016","journal-title":"CMGH"},{"key":"10.1016\/j.bpg.2019.02.005_bib44","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.22193","article-title":"The role of matrix stiffness in regulating cell behavior","volume":"47","author":"Wells","year":"2008","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.bpg.2019.02.005_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.MIB.0000437615.98881.31","article-title":"Novel Rho\/MRTF\/SRF inhibitors block matrix-stiffness and TGF-\u03b2-induced fibrogenesis in human colonic myofibroblasts","volume":"20","author":"Johnson","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/pr.114.009381","article-title":"The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis","volume":"67","author":"Knipe","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bpg.2019.02.005_bib47","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bpg.2019.02.005_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0168-8278(95)80424-2","article-title":"Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation","volume":"22","author":"Lin","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.bpg.2019.02.005_bib49","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.bpg.2019.02.005_bib50","doi-asserted-by":"crossref","first-page":"190ps10","DOI":"10.1126\/scitranslmed.3004731","article-title":"The gut microbiome in intestinal fibrosis: environmental protector or provocateur?","volume":"5","author":"Rieder","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bpg.2019.02.005_bib51","doi-asserted-by":"crossref","first-page":"G786","DOI":"10.1152\/ajpgi.00059.2012","article-title":"Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease","volume":"303","author":"Rieder","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bpg.2019.02.005_bib52","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2010.06.070","article-title":"Risk factors associated with progression to intestinal complications of Crohn\u2019s disease in a population-based cohort","volume":"139","author":"Thia","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2019.02.005_bib53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","article-title":"Long-term evolution of disease behavior of Crohn\u2019s disease","volume":"8","author":"Cosnes","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/apt.14853","article-title":"An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn\u2019s disease","volume":"48","author":"Rieder","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2019.02.005_bib55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s004280000226","article-title":"Significant association of strictures and internal fistula formation in Crohn\u2019s disease","volume":"437","author":"Oberhuber","year":"2000","journal-title":"Virchows Arch"},{"key":"10.1016\/j.bpg.2019.02.005_bib56","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00535-010-0231-7","article-title":"The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn\u2019s disease independent of the IL23R genotype","volume":"45","author":"Jurgens","year":"2010","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib57","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ecco-jcc\/jjw055","article-title":"European crohn\u2019s and colitis organisation topical review on prediction, diagnosis and management of fibrostenosing crohn\u2019s disease","volume":"10","author":"Rieder","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.bpg.2019.02.005_bib58","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/j.gastro.2013.10.047","article-title":"American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-alpha biologic drugs for the induction and maintenance of remission in inflammatory Crohn\u2019s disease","volume":"145","author":"Terdiman","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2019.02.005_bib59","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/MEG.0000000000000102","article-title":"Serum antibodies to microbial antigens for Crohn\u2019s disease progression: a meta-analysis","volume":"26","author":"Xiong","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2019.02.005_bib60","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/ibd.21179","article-title":"Serum anti-glycan antibodies predict complicated Crohn\u2019s disease behavior: a cohort study","volume":"16","author":"Rieder","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib61","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1111\/j.1440-1746.2007.05121.x","article-title":"Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn\u2019s disease","volume":"23","author":"Erzin","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2019.02.005_bib62","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ajg.2011.19","article-title":"The prognostic power of the NOD2 genotype for complicated Crohn\u2019s disease: a meta-analysis","volume":"106","author":"Adler","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib63","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3748\/wjg.v18.i5.412","article-title":"Role of ATG16L, NOD2 and IL23R in Crohn\u2019s disease pathogenesis","volume":"18","author":"Naser","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib64","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0140-6736(17)30317-3","article-title":"Prediction of complicated disease course for children newly diagnosed with Crohn\u2019s disease: a multicentre inception cohort study","volume":"389","author":"Kugathasan","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2019.02.005_bib65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2036.2011.04710.x","article-title":"Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn\u2019s disease","volume":"34","author":"Panes","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2019.02.005_bib66","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1111\/j.1572-0241.2007.01537.x","article-title":"Correlation of CT enteroclysis with surgical pathology in Crohn\u2019s disease","volume":"102","author":"Chiorean","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib67","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ibd.21801","article-title":"Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn\u2019s disease","volume":"18","author":"Adler","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib68","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ajg.2014.424","article-title":"Characterization of inflammation and fibrosis in crohn\u2019s disease lesions by magnetic resonance imaging","volume":"110","author":"Rimola","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib69","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00330-013-3015-7","article-title":"Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn\u2019s disease assessment with histopathology of surgical specimens","volume":"24","author":"Tielbeek","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.bpg.2019.02.005_bib70","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1148\/radiol.10091648","article-title":"Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease","volume":"259","author":"Adler","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.bpg.2019.02.005_bib71","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ecco-jcc\/jjv207","article-title":"PET\/MR versus PET\/CT imaging: impact on the clinical management of small-bowel crohn\u2019s disease","volume":"10","author":"Pellino","year":"2016","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.bpg.2019.02.005_bib72","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1148\/radiol.13121775","article-title":"US elastography-derived shear wave velocity helps distinguish acutely inflamed from fibrotic bowel in a Crohn disease animal model","volume":"267","author":"Dillman","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.bpg.2019.02.005_bib73","first-page":"265","article-title":"Risk of colorectal cancer in Crohn\u2019s disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary","volume":"22","author":"Lovasz","year":"2013","journal-title":"J\u00a0Gastrointest Liv Dis: JGLD"},{"key":"10.1016\/j.bpg.2019.02.005_bib74","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.cgh.2015.04.185","article-title":"Detection of dysplasia or cancer in 3.5% of patients with inflammatory bowel disease and colonic strictures","volume":"13","author":"Fumery","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2019.02.005_bib75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd european evidence-based consensus on the diagnosis and management of crohn\u2019s disease 2016: Part 1: diagnosis and medical management","volume":"11","author":"Gomollon","year":"2017","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.bpg.2019.02.005_bib76","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00004836-198306000-00003","article-title":"Prognosis for nonoperative management of small-bowel obstruction in Crohn\u2019s disease","volume":"5","author":"Yaffe","year":"1983","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib77","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.crohns.2014.07.007","article-title":"The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease","volume":"8","author":"Nguyen","year":"2014","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.bpg.2019.02.005_bib78","first-page":"2503","article-title":"Intestinal strictures complicating initially successful infliximab treatment for luminal Crohn\u2019s disease","volume":"95","author":"Vasilopoulos","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib79","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1572-0241.2006.00463.x","article-title":"Factors associated with the development of intestinal strictures or obstructions in patients with Crohn\u2019s disease","volume":"101","author":"Lichtenstein","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib80","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2019.02.005_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/gutjnl-2016-312581","article-title":"Efficacy of adalimumab in patients with Crohn\u2019s disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study","volume":"67","author":"Bouhnik","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2019.02.005_bib82","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MIB.0000000000000988","article-title":"A\u00a0pooled analysis of efficacy, safety, and long-term outcome of endoscopic balloon dilation therapy for patients with stricturing crohn\u2019s disease","volume":"23","author":"Bettenworth","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib83","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.cgh.2018.02.035","article-title":"Outcomes of endoscopic balloon dilation vs surgical resection for primary ileocolic strictures in patients with crohn\u2019s disease","volume":"16","author":"Lan","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2019.02.005_bib84","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2036.2012.05146.x","article-title":"Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn\u2019s disease","volume":"36","author":"Gustavsson","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2019.02.005_bib85","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.crohns.2013.10.001","article-title":"Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn\u2019s disease strictures","volume":"8","author":"Atreja","year":"2014","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.bpg.2019.02.005_bib86","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/gut.2009.180182","article-title":"Long-term outcome of endoscopic dilatation in patients with Crohn\u2019s disease is not affected by disease activity or medical therapy","volume":"59","author":"Thienpont","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2019.02.005_bib87","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ecco-jcc\/jjw072","article-title":"Endoscopic dilatation of crohn\u2019s anastomotic strictures is effective in the long term, and escalation of medical therapy improves outcomes in the biologic era","volume":"10","author":"Ding","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.bpg.2019.02.005_bib88","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.gie.2010.08.003","article-title":"Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn\u2019s disease with stricture: a prospective, randomized, double-blind, controlled trial","volume":"72","author":"Di Nardo","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2019.02.005_bib89","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cgh.2007.04.013","article-title":"A\u00a0pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn\u2019s strictures","volume":"5","author":"East","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2019.02.005_bib90","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ibd.20318","article-title":"Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn\u2019s colitis","volume":"14","author":"Swaminath","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib91","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00384-005-0739-0","article-title":"Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn\u2019s disease","volume":"21","author":"Sorrentino","year":"2006","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib92","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/ibd.21739","article-title":"Endoprosthetic management of refractory ileocolonic anastomotic strictures after resection for Crohn\u2019s disease: report of nine-year follow-up and review of the literature","volume":"18","author":"Levine","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib93","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3748\/wjg.v20.i9.2212","article-title":"Biodegradable stents in gastrointestinal endoscopy","volume":"20","author":"Lorenzo-Zuniga","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib94","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/ibd.22844","article-title":"Safety and efficacy of extractible self-expandable metal stents in the treatment of Crohn\u2019s disease intestinal strictures: a prospective pilot study","volume":"18","author":"Attar","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib95","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/MIB.0000000000001044","article-title":"Endoscopic stricturotomy with needle knife in the treatment of strictures from inflammatory bowel disease","volume":"23","author":"Lan","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib96","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1365-2036.2007.03515.x","article-title":"Early versus late surgery for ileo-caecal Crohn\u2019s disease","volume":"26","author":"Aratari","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2019.02.005_bib97","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.dld.2008.09.010","article-title":"Clinical course of Crohn\u2019s disease first diagnosed at surgery for acute abdomen","volume":"41","author":"Latella","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib98","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.gassur.2003.08.007","article-title":"Short bowel syndrome and Crohn\u2019s disease","volume":"7","author":"Thompson","year":"2003","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.bpg.2019.02.005_bib99","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/DCR.0b013e31824f875a","article-title":"Comparison of conventional and nonconventional strictureplasties in Crohn\u2019s disease: a systematic review and meta-analysis","volume":"55","author":"Campbell","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.bpg.2019.02.005_bib100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/bjs.5179","article-title":"Long-term follow-up of strictureplasty for Crohn\u2019s disease","volume":"93","author":"Fearnhead","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.bpg.2019.02.005_bib101","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00464-005-0500-3","article-title":"Comparison of laparoscopic and open ileocecal resection for Crohn\u2019s disease: a metaanalysis","volume":"20","author":"Tilney","year":"2006","journal-title":"Surg Endosc"},{"key":"10.1016\/j.bpg.2019.02.005_bib102","first-page":"598","article-title":"Risk factors for postoperative recurrence of Crohn\u2019s disease with emphasis on surgical predictors","volume":"30","author":"Gklavas","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.bpg.2019.02.005_bib103","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/apt.12176","article-title":"Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn\u2019s disease","volume":"37","author":"Gustavsson","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2019.02.005_bib104","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(09)60322-6","article-title":"Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I\/II studies","volume":"373","author":"Ferguson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2019.02.005_bib105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000072820","article-title":"Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients","volume":"23","author":"el-Agroudy","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.bpg.2019.02.005_bib106","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1053\/gast.2002.33367","article-title":"Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C","volume":"122","author":"Arthur","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2019.02.005_bib107","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MIB.0000000000000598","article-title":"Reversibility of stricturing crohn\u2019s disease-fact or fiction?","volume":"22","author":"Bettenworth","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2019.02.005_bib108","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1755-1536-7-5","article-title":"Medical therapy of stricturing Crohn\u2019s disease: what the gut can learn from other organs - a systematic review","volume":"7","author":"Bettenworth","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bpg.2019.02.005_bib109","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1164\/rccm.201602-0258RR","article-title":"Pirfenidone for idiopathic pulmonary fibrosis","volume":"194","author":"Adams","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bpg.2019.02.005_bib110","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A\u00a0phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpg.2019.02.005_bib111","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1183\/09031936.00005209","article-title":"Pirfenidone in idiopathic pulmonary fibrosis","volume":"35","author":"Taniguchi","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bpg.2019.02.005_bib112","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ecco-jcc\/jjv230","article-title":"Modified side-to-side isoperistaltic strictureplasty over the ileocaecal valve: an alternative to ileocaecal resection in extensive terminal ileal crohn\u2019s disease","volume":"10","author":"de Buck van Overstraeten","year":"2016","journal-title":"J\u00a0Crohn\u2019s Colitis"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691819300046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691819300046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:01:46Z","timestamp":1761498106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691819300046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":112,"alternative-id":["S1521691819300046"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2019.02.005","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting anti-fibrotic pathways in Crohn\u2019s disease \u2013 The final frontier?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101603"}}